DR. REDDY'S LABORATO

500124
End-of-day quote. End-of-day quote  - 11/26
4898.8INR +1.92%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).

Number of employees : 21 650 people.
Sales per Business
20192020
INR
(in Million)
%INR
(in Million)
%
Global Generics 122,90379.9% 138,12379.1%
Pharmaceutical Services and Active Ingredients 24,14015.7% 25,74714.7%
Proprietary Products 4,7503.1% 7,9494.6%
Others 2,0581.3% 2,7811.6%
Sales per region
20192020
INR
(in Million)
%INR
(in Million)
%
United States 69,29945% 76,02843.5%
Others 40,44926.3% 49,58328.4%
India 28,80418.7% 32,08918.4%
Russia 15,2999.9% 16,9009.7%
Managers
Name Title
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Bruce Leonard Andrews Carter Independent Non-Executive Director
Sridar Arvamudhan Iyengar Independent Non-Executive Director
Bharat Narotam Doshi Independent Non-Executive Director
Prasad Raghava Menon Lead Independent Director
Leo Puri Independent Director
Shareholders
Name Equities %
Dr. Reddy's Holdings Ltd. 41,325,300 24.9%
First Sentier Investors (Australia) IM Ltd. 8,208,902 4.94%
SBI Funds Management Pvt Ltd. 4,364,168 2.62%
Axis Asset Management Co. Ltd. 2,983,028 1.79%
Life Insurance Corp of India 2,650,211 1.59%
BlackRock Fund Advisors 2,527,389 1.52%
Aditya Birla Sun Life AMC Ltd. 2,460,612 1.48%
ICICI Prudential Life Insurance Co. Ltd. (Invt Port) 2,459,754 1.48%
The Vanguard Group, Inc. 2,453,912 1.48%
DSP Investment Managers Pvt Ltd. 1,982,564 1.19%
Company contact information
Banjara Hills 3 8-2-337 Road
IN-500 016 Hyderabad, Andhra Pradesh


Phone : +91 40 4900 2900
Fax : +91 40 4900 2999
web site : https://www.drreddys.com/
Markets and indexes
-
- Main Market
- CNX Nifty /
Stock Exchange Codes
- ISIN Code :  INE089A01023
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
DR. REDDY'S LABORATORIES LIMITED58.53%10 807
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-4.41%282 585
PFIZER INC.-1.59%203 048
NOVARTIS AG-11.88%202 620
MERCK & CO., INC.-11.97%202 555
ABBVIE INC.17.69%183 962
NOVO NORDISK A/S6.40%152 415
BRISTOL-MYERS SQUIBB COMPANY-2.10%142 003
ASTRAZENECA PLC2.54%137 013
ELI LILLY AND COMPANY10.13%131 228
AMGEN INC.-8.61%128 258
SANOFI-6.03%126 012
GLAXOSMITHKLINE PLC-22.51%91 855
CHUGAI PHARMACEUTICAL CO., LTD.42.95%73 525
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 214
DAIICHI SANKYO COMPANY, LIMITED56.60%68 978
BAYER AG-32.50%57 498
TAKEDA PHARMACEUTICAL COMPANY LIMITED-15.03%55 234
ASTELLAS PHARMA INC.-15.08%28 729
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED36.49%26 384